Remove Manufacturing Remove Pharma Remove Prescription Remove Safety
article thumbnail

Should we be worried about pharma’s supply chain?

World of DTC Marketing

QUICK READ: Pharma supply chain issues are a concern for us all but especially patients. Hedley Rees has written a book on pharma supply chains that is eye-opening and downright scary. We need a 21st-century approach that puts patient safety first. In other words, money over safety. Patients should be scared.

article thumbnail

GAMP 5 update: computerized system expectations for pharma manufacturers

European Pharmaceutical Review

As ISPE GAMP 5 Second Edition notes in the preface “Operating in a highly regulated industry may lead practitioners to apply prescriptive and rigid compliance-based approaches that are not commensurate with and not effective in managing any actual risk to the product and the patient.” Takeaways from ISPE’s GAMP 5 Second Edition update.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

US legislative update: takeaways for European pharma

European Pharmaceutical Review

In the current US Congressional session, Congress has focused heavily on legislation directed at reducing prescription drug prices. The new law will also require drug manufacturers to pay rebates to Medicare if they increase drug prices faster than consumer inflation. 5) monitoring access to biosimilars.

article thumbnail

Leading speciality pharmacies in pharma

Pharmaceutical Technology

Pharmaceutical Technology has listed the top speciality pharmacies in pharma based on its intel, insights, and decades of experience in the sector. Patient monitoring for safety and efficacy. Payer and/or manufacturer reporting. Prescription refill and renewal. Patient monitoring for safety and efficacy.

article thumbnail

AbbVie CEO looks like a fool before Congress

World of DTC Marketing

While AbbVie is a poster for everything wrong with pharma, what they have done doesn’t apply to ALL pharma companies. According to CNBC “AbbVie workers say they worry that the company is putting profits ahead of safety and the health of its U.S. 27 email outlining its process for bringing thousands of U.S.

Pharma 181
article thumbnail

10 New Solutions, Strategies, and Devices to Boost Adherence

PM360

The combined solution enables health plans and self-insured employers to realize immediate pharmacy cost savings and near-term medical cost reductions by integrating Levrx’s plan-specific and real-time prescription insights into the Adhere Platform medication optimization offerings. The Andaman7 Platform Solution. Vincent Keunen.

article thumbnail

Key Developments from AMCP 2023 on Blockbuster Generics, Diabetes Drugs, PBM Legislation, and More

PM360

Attention deficit hyperactivity disorder (ADHD) drug Vyvanse (lisdexamfetamine dimesylate) , manufactured by Takeda, also is facing generic competition. The 505(b)(2) New Drug Application process is a streamlined approval pathway for manufacturers to submit new drug applications.